Literature DB >> 3579255

Effect of hemorrhagic shock on cefazolin and gentamicin pharmacokinetics in dogs.

P L Dickson, J T DiPiro, K A Michael, R P Cheung, E M Hall.   

Abstract

The physiologic response to traumatic injury may alter the disposition of drugs and thereby affect their therapeutic or toxic potential. A study was conducted in 10 mongrel dogs to determine the effect of experimental hemorrhagic shock with resuscitation on the pharmacokinetics of gentamicin and cefazolin. Single simultaneous intravenous doses of gentamicin (3 mg/kg) and cefazolin (25 mg/kg) were administered to each animal on an initial study day, after which serial blood and urine collections were performed. After 1 week, a standard hemorrhagic shock model was applied to each animal. Shock was continued for 1 h, after which the animal was resuscitated with either whole blood or saline. After stabilization for 20 min, a second dose of gentamicin and cefazolin was administered, and blood and urine were again collected. Drug clearance was not significantly altered, except for that of cefazolin after saline resuscitation, for which there was a significant increase in drug clearance. After both methods of resuscitation an increase in the volume of distribution was noted for cefazolin and gentamicin. Drug half-life was noted to be increased after shock for cefazolin by both resuscitation methods and for gentamicin after shock by saline resuscitation. Although alterations of pharmacokinetic parameters were noted, mean concentrations of gentamicin and cefazolin in serum were similar for pre- and postshock phases.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3579255      PMCID: PMC174738          DOI: 10.1128/AAC.31.3.389

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Renal considerations in the injured patient.

Authors:  C E Lucas
Journal:  Surg Clin North Am       Date:  1982-02       Impact factor: 2.741

2.  Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma.

Authors:  M E Jolley; S D Stroupe; C H Wang; H N Panas; C L Keegan; R L Schmidt; K S Schwenzer
Journal:  Clin Chem       Date:  1981-07       Impact factor: 8.327

3.  In vitro inactivation of tobramycin by cephalosporins.

Authors:  W J Spruill; C Y McCall; G E Francisco
Journal:  Am J Hosp Pharm       Date:  1985-11

4.  Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring.

Authors:  R J Tindula; P J Ambrose; A F Harralson
Journal:  Drug Intell Clin Pharm       Date:  1983-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.